Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.
about
Evaluation of current cancer immunotherapy: hemato-oncologyMolecular matching in allogeneic bone marrow transplantation.Advances in graft-versus-host disease biology and therapy.Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisitedHighly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamideThe human application of gene therapy to re-program T-cell specificity using chimeric antigen receptorsNovel approaches to allogeneic stem cell therapy.Alemtuzumab: a novel monoclonal antibody.Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation.'GVHD': graft-versus-host disease or graft-versus-Hodgkin's disease? An old acronym with new meaning.Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.Oral chronic graft-versus-host disease: current pathogenesis, therapy, and researchGraft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantationDifferent effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemiaAutografting as first line treatment for chronic myeloid leukaemia.Notch signaling in hematopoietic cell transplantation and T cell alloimmunity.Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.Novel application of lentiviral vectors towards treatment of graft-versus-host disease.Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation.Is there a role for allogeneic transplantation in chronic myeloid leukemia?Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.What does one do for the CML patient in relapse after allogeneic bone marrow transplantation?Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation.CD34 positive blood cells for allogeneic progenitor and stem cell transplantation.Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD.Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion MedicineThe effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant.Genetically enhanced T lymphocytes and the intensive care unit.
P2860
Q27006179-D2C94925-0942-40A5-8CE2-D0149BB53BDDQ33539331-ED87AB7A-6E89-4446-A2C9-3D725CC2FC3AQ34031916-B8946914-6E2D-409E-94FA-D04741855FA4Q34065058-B1FF22AF-C5D9-43D9-ADEF-DED1CD27C18CQ34111303-DDCE9430-3612-4D72-A571-AC74E6FFD98FQ34309388-0D956B76-6235-4D62-A040-269A469BBB5AQ34452114-EA44E2A3-5087-4163-B09C-AE89A53B051BQ34452735-003610BD-0A8F-46D7-A190-C8887FB13492Q34573989-A5661075-10AF-4A15-8A7C-FE15672D9EDAQ35122185-AE148614-D5EB-4A8D-ACA8-1E544BD9484FQ35752628-461C715A-6F15-4021-8ADA-BBD0B86D103DQ35849064-2825E319-1A7A-4B50-A76D-3C5083DCF6ECQ36028584-6FBB30C6-6F77-4BCE-BCF7-8575F0415049Q36579263-5FFD660A-E6A8-4320-B0D0-062280E96A65Q36763834-9DF9B0DB-3CA2-4A16-ADB9-0656E4D02FB4Q36805898-BE255959-02D8-4AC9-B2D5-60AC37D02044Q37217601-2FFA128C-9443-440F-9A2C-529FF1A6022CQ37325713-3D085401-795D-464C-9273-4A80B460FB04Q37357027-CDF5C1D4-0946-432F-857A-6AC74F02EEC5Q37489887-549DE3BC-62C6-47C6-BAFC-9BA8CBEDB0E9Q38066586-C62B45B5-D16C-45BF-A67A-BD64CC759F64Q38161964-871F8BF7-0999-4696-8A36-48B2BB6C5CB7Q38488058-12FC7233-8F3D-4761-A551-46469F796652Q40764861-B6F20356-B5AE-4C1B-9C86-883CEFE8AB4BQ40785933-222D74F9-E5B4-4968-B5B1-6A9BBF4041F3Q40820085-A001A1EA-B7F0-4579-AB3B-CA8D1AAA100BQ40958061-51212F4E-4FB0-4FD2-A9F4-B7A594001435Q41655891-56358931-8D19-4144-9CAD-532654DE106AQ42382210-8358AEB9-997D-4412-8717-0823F3AA34CDQ42783189-15E322B0-8B87-4332-82B7-F67EF00492EAQ43635761-48EBCD0B-DF10-446E-8DAA-55E348E5146CQ44511393-F542EB9D-EF21-4E71-A12D-8FD79BB76085Q51990914-CEA31784-143C-4DBF-8EEA-0868CFCCFCEBQ55380614-D0208793-AD18-4609-9E80-33C054AED6EB
P2860
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Bone marrow transplantation fo ...... graft-versus-leukaemia effect.
@en
Bone marrow transplantation fo ...... graft-versus-leukaemia effect.
@nl
type
label
Bone marrow transplantation fo ...... graft-versus-leukaemia effect.
@en
Bone marrow transplantation fo ...... graft-versus-leukaemia effect.
@nl
prefLabel
Bone marrow transplantation fo ...... graft-versus-leukaemia effect.
@en
Bone marrow transplantation fo ...... graft-versus-leukaemia effect.
@nl
P2093
P2860
P1476
Bone marrow transplantation fo ...... graft-versus-leukaemia effect.
@en
P2093
Apperley JF
Goldman JM
Mandelli F
P2860
P304
P356
10.1111/J.1365-2141.1988.TB07628.X
P407
P577
1988-06-01T00:00:00Z